Status:
UNKNOWN
Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
Melanoma
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study is a diagnostic study. Patients and healthy volunteers were recruited from clinically suspected or confirmed melanoma patients to undergo 18F-PEG3-FPN PET/MR or PET/CT imaging to observe th...
Detailed Description
This team always picolinamide structure based, successfully synthesized a positron nuclide targeting melanin probe - 18-5 - f FPN \[18 f - 5 - fluoro - N - (2 - (diethyl amino) ethyl) pyridine formami...
Eligibility Criteria
Inclusion
- Adult patients (age 18 years or above), regardless of gender；
- Patients with clinically suspected or confirmed melanoma (supporting evidence including visual examination, MRI, CT, ultrasound, and histomathological examination, etc.) who agree to undergo histomathological examination (if not performed before imaging) and 18F-FDG PET imaging;Healthy volunteers;
- The patient or his legal representative can sign the informed consent.
Exclusion
- Acute systemic diseases and electrolyte disturbances;
- Pregnant or lactating women;
- The patient or his legal representative is unable or unwilling to sign the informed consent.
Key Trial Info
Start Date :
January 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04747561
Start Date
January 12 2021
End Date
December 31 2023
Last Update
February 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China, Hubei Province
Wuhan, Hubei, China, 430022